The Brazilian Health Regulatory Agency’s (ANVISA) inspection was conducted at Caplin Point Labs’ Chennai facility between 12 and 16 August 2024 and concluded with zero observations.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
